MHC associations with clinical and autoantibody manifestations in European SLE

Morris, DL; Fernando, MMA; Taylor, KE; Chung, SA; Nititham, J; Alarcón-Riquelme, ME; Barcellos, LF; Behrens, TW; Cotsapas, C; Gaffney, PM; Graham, RR; Pons-Estel, BA; Gregersen, PK; Harley, JB; Hauser, SL; Hom, G; Langefeld, CD; Noble, JA; Rioux, JD; Seldin, MF; Vyse, TJ; Criswell, LA

doi:10.1038/gene.2014.6

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

MHC associations with clinical and autoantibody manifestations in European SLE

Published Date:

Mar 06 2014

Publisher's site:

http://dx.doi.org/10.1038/gene.2014.6 New Site Icon

Source:

Genes Immun. 2014; 15(4):210-217.

[PDF-324.50 KB]

Details:

Alternative Title:

Genes Immun

Personal Author:

Morris, DL ; Fernando, MMA ; Taylor, KE ; Chung, SA ; Nititham, J ; ... More ▼

Corporate Authors:

Systemic Lupus Erythematosus Genetics Consortium

Description:

Systemic lupus erythematosus (SLE) is a clinically heterogeneous disease affecting multiple organ systems and characterized by autoantibody formation to nuclear components. Although genetic variation within the major histocompatibility complex (MHC) is associated with SLE, its role in the development of clinical manifestations and autoantibody production is not well defined. We conducted a meta-analysis of four independent European SLE case collections for associations between SLE sub-phenotypes and MHC single-nucleotide polymorphism genotypes, human leukocyte antigen (HLA) alleles and variant HLA amino acids. Of the 11 American College of Rheumatology criteria and 7 autoantibody sub-phenotypes examined, anti-Ro/SSA and anti-La/SSB antibody subsets exhibited the highest number and most statistically significant associations. HLA-DRB1*03:01 was significantly associated with both sub-phenotypes. We found evidence of associations independent of MHC class II variants in the anti-Ro subset alone. Conditional analyses showed that anti-Ro and anti-La subsets are independently associated with HLA-DRB1*0301, and that the HLA-DRB1*03:01 association with SLE is largely but not completely driven by the association of this allele with these sub-phenotypes. Our results provide strong evidence for a multilevel risk model for HLA-DRB1*03:01 in SLE, where the association with anti-Ro and anti-La antibody-positive SLE is much stronger than SLE without these autoantibodies.

Subject:

[+]

Pubmed ID:

24598797

Pubmed Central ID:

PMC4102853

Document Type:

Journal Article

Funding:

076113/Wellcome Trust/United Kingdom ; 085475/Wellcome Trust/United Kingdom ; 17761/PI/Arthritis Research UK/United Kingdom ; 18239/Arthritis Research UK/United Kingdom ; 5 M01 RR-00079/RR/NCRR NIH HHS/United States ; ... More ▼

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

	license.txt	text/plain
	NIHMS595460-supplement-Supplementary_table_1.docx	application/vnd.openxmlformats-officedocument.wordprocessingml.document
	nihms595460.nxml	text/plain
	nihms595460f1.gif	image/gif
	nihms595460f1.jpg	image/jpeg

No Related Documents.

You May Also Like:

Analysis of Autoantibody Profiles in Two Asbestiform Fiber Exposure Cohorts

Personal Author:

Pfau, Jean C.; Barbour, Christopher; Black, Brad; Serve, Kinta M.; Fritzler, Marvin J.;

Published Date:

September 19 2018

Source:

J Toxicol Environ Health A. 81(19):1015-1027

Description:

An increased risk for Systemic Autoimmune Diseases (SAID) was reported in the population of Libby, Montana, where extensive exposure to asbestiform amphiboles occurred through mining and use of asbestiform fiber-laden vermiculite. High frequencies of...

File Type:

[PDF - 1.18 MB]
Rheumatic autoimmune diseases in women and midlife health

Personal Author:

Marder, Wendy; Vinet, Évelyne; Somers, Emily C.;

Published Date:

December 02 2015

Source:

Womens Midlife Health. 1

Description:

Autoimmune diseases such as systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and systemic sclerosis (scleroderma) preferentially affect women, and are characterized by systemic inflammation leading to target organ dysfunction. The publi...

File Type:

[PDF - 355.43 KB]
Antiphospholipid Syndrome Laboratory Testing and Diagnostic Strategies

Personal Author:

Ortel, Thomas L.

Published Date:

Mar 31 2012

Source:

Am J Hematol. 87(Suppl 1):S75-S81.

Description:

The antiphospholipid syndrome (APS) is diagnosed in patients with recurrent thromboembolic events and/or pregnancy loss in the presence of persistent laboratory evidence for antiphospholipid antibodies. Diagnostic tests for the detection of antiphosp...

File Type:

[PDF - 376.02 KB]
Clinical Characteristics and Treatment Outcomes for Patients Infected with Mycobacterium haemophilum

Personal Author:

Nookeu, Pornboonya; Angkasekwinai, Nasikarn; Foongladda, Suporn; Phoompoung, Pakpoom;

Published Date:

Sep 2019

Source:

Emerg Infect Dis. 25(9):1648-1652

Description:

Mycobacterium haemophilum is a nontuberculous mycobacterium that can infect immunocompromised patients. Because of special conditions required for its culture, this bacterium is rarely reported and there are scarce data for long-term outcomes. We con...

File Type:

[PDF - 1.13 MB]
Dietary omega polyunsaturated fatty acid intake and patient-reported outcomes in systemic lupus erythematosus: The Michigan Lupus Epidemiology & Surveillance (MILES) Program

Personal Author:

Charoenwoodhipong, Prae; Harlow, Sioban D.; Marder, Wendy; Hassett, Afton L.; McCune, W. Joseph; Gordon, Caroline; Helmick, Charles G.; Barbour, Kamil E.; Wang, Lu; Mancuso, Peter; Somers, Emily C.; Zick, Suzanna M.;

Published Date:

Jul 2020

Source:

Arthritis Care Res (Hoboken). 72(7):874-881

Description:

Objective:To examine associations between dietary intake of omega-3 (n-3; generally anti-inflammatory) and omega-6 (n-6; generally pro-inflammatory) fatty acids and patient-reported outcomes in systemic lupus erythematosus (SLE).Methods:This study wa...

Public Access
Available on:

July 01, 2021